| Schedule (route) | Endpoint | Vehicle | Dose | Treated/Control (%) | Observations |
|---|---|---|---|---|---|
| Q01DX009 (ip) | median survival time | saline | 13.3 mg/kg/injection | 222.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 20.0 mg/kg/injection | 222.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX009 (ip) | median survival time | saline | 27.0 mg/kg/injection | 203.0 | Antitumor endpoint evaluated on day 30; 10/10 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | survival time, mean or median | saline | 5.0 mg/kg/injection | 110.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | survival time, mean or median | saline | 10.0 mg/kg/injection | 143.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | survival time, mean or median | saline | 20.0 mg/kg/injection | 283.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |
| Q01DX010 (ip) | survival time, mean or median | saline | 40.0 mg/kg/injection | 203.0 | Experiment continued until the death of all animals; 06/06 animals surviving on tox evaluation day (usually day 5) |